The NoLoCo Strategy for Essential Hypertension

Authors

F. Matthew Mihelic MD, University of Tennessee Health Science Center

Document Type

Article

Publication Date

8-31-2023

Abstract

Ninety-nine percent of all “essential” hypertension can be controlled by using the NoLoCo strategy, without causing any significant side-effects and without an increase in insulin resistance. NoLoCo stands for Norvasc (amlodipine), Lozol (indapamide), and Cozaar (losartan), but the medicines are considered and used in reverse order.

Recommended Citation

Mihelic, F. Matthew MD, "The NoLoCo Strategy for Essential Hypertension" (2023). Faculty Publications. 21.
https://dc.uthsc.edu/gsmk_facpubs/21